Sign In
Last checked at 
28 Apr 2017 14:30
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Khalid Nabilsi |
2 | Reason for the notification | |
a) | Position/status | Chief Financial Officer |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Disposal of 19,500 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. |
c) | Price(s) and volume(s) | Price(s): £19.36 Volume(s): 19,500 |
d) | Aggregated information
| Volume: 19,500 Price: £19.36 Total: £377,520.00 |
e) | Date of the transaction | 28 April 2017 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Follow the stocks
